Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Endeavor Biomedicines, Inc.
Eli Lilly and Company
St. Jude Children's Research Hospital
Gustave Roussy, Cancer Campus, Grand Paris
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Shanghai 6th People's Hospital
Institut Bergonié
University of Minnesota
Milton S. Hershey Medical Center
University of Milano Bicocca
Hospices Civils de Lyon
M.D. Anderson Cancer Center
Institut Bergonié
Children's Oncology Group